Loading: 100%
Medtronic plc logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 84,000 (as per Q2 2017)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker MDTno data available
Financial year endsFY ends End of Aprilno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 176472808896
datesClosing price (adj.)
13.10.201778.07
11.10.201778.24
04.10.201778.63
27.09.201777.38
20.09.201779.69
13.09.201781.45
06.09.201779.40
30.08.201779.39
23.08.201779.28
16.08.201784.10
09.08.201783.46
02.08.201782.71
26.07.201785.24
19.07.201785.15
12.07.201787.29
05.07.201788.38
27.06.201787.81
20.06.201787.84
13.06.201786.24
06.06.201785.05
30.05.201783.93
23.05.201783.68
16.05.201783.02
09.05.201782.42
02.05.201783.82
25.04.201780.87
18.04.201779.45
11.04.201779.27
04.04.201779.73
28.03.201779.85
21.03.201779.80
14.03.201781.18
07.03.201780.08
28.02.201779.60
21.02.201779.25
14.02.201775.80
07.02.201774.88
31.01.201774.79
24.01.201772.63
17.01.201774.59
10.01.201773.68
03.01.201769.46
27.12.201670.61
19.12.201671.48
12.12.201672.08
05.12.201670.09
28.11.201672.35
21.11.201678.80
14.11.201677.01
07.11.201682.09
31.10.201680.21
24.10.201681.46
17.10.201680.75
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
78.07n/a
Market Capitalisation
in million USD
109,221n/a
Enterprise Value
in million USD
128,550n/a
Common Shares Outstanding
as per Apr 29, 2016
1,399,018,022n/a
Preferred Shares Outstanding
as per Apr 29, 2016
n/a
Average Basic Shares Outstanding
TTM
1,395,100,000n/a
Average Diluted Shares Outstanding
TTM
1,409,700,000n/a
Index Membership
n/a
Business Summary
Medtronic PLC is a medical technology company. It primarily manufacture and sell device-based medical therapies. It operates in Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies and Diabetes segments.
no data available
Key Financials & Ratios (all figures TTM as per Jul 31, 2016, million USD, full statements further below)
Profit & Loss
Revenues 28,725n/a
Gross Profit 19,778n/a
Operating Income 6,171n/a
EBITDA 9,027n/a
Net Profit 3,647n/a
Balance Sheet
Cash and Cash Equivalents 12,810n/a
Receivables 5,357n/a
Total Current Assets 23,498n/a
PP&E 4,814n/a
Total Assets 98,601n/a
Accounts Payable 1,615n/a
Current Debt 1,947n/a
Total Current Liabilities 7,896n/a
Long-Term Debt 30,124n/a
Total Liabilities 47,709n/a
Total Equity 50,892n/a
Cash Flow
Depreciation & Amortisation 2,856n/a
Change in Working Capital -545n/a
Operating Cash Flow 5,952n/a
Net Change in PP&E and Intangibles -1,152n/a
Investing Cash Flow 2,947n/a
Dividends Paid -2,200n/a
Financing Cash Flow -8,959n/a
Total Change in Cash 81n/a
Free Cash Flow 6,593n/a
Profitability Ratios
Gross Margin 68.9%n/a
Operating Margin 21.5%n/a
Net Profit Margin 12.7%n/a
Return on Equity 7.2%n/a
Return on Assets 3.7%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 14.24n/a
EV/Sales 4.48n/a
Book to Market Value 0.47n/a
Other Ratios
Current Ratio 297.6%n/a
Liabilities to Equity Ratio 93.8%n/a
Debt to Assets Ratio 32.5%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15FY '16
Revenue
16,590
17,005
20,261
28,833
Sales & Services Revenue
0
0
0
0
Financing Revenue
0
0
0
0
Other Revenue
0
0
0
0
Cost of revenue
-4,126
-4,333
-6,309
-9,142
Cost of Goods & Services
0
0
0
0
Cost of Financing Revenue
0
0
0
0
Cost of Other Revenue
0
0
0
0
Gross Profit
12,464
12,672
13,952
19,691
Other Operating Income
0
0
0
0
Operating Expenses
-7,586
-7,673
-9,277
-13,624
Selling, General & Administrative
-5,698
-5,847
-6,904
-9,469
Selling & Marketing
0
0
0
0
General & Administrative
0
0
0
0
Research & Development
-1,557
-1,477
-1,640
-2,224
Depreciation & Amortization
-331
-349
-733
-1,931
Provision For Doubtful Accounts
0
0
0
0
Other Operating Expense
0
0
0
0
Operating Income (Loss)
4,878
4,999
4,675
6,067
Non-Operating Income (Loss)
-259
-289
-398
-1,062
Interest Expense, net
-151
-108
-280
-955
Interest Expense
0
0
0
0
Interest Income
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
Other Non-Operating Income (Loss)
-108
-181
-118
-107
Pretax Income (Loss), Adjusted
4,619
4,710
4,277
5,005
Abnormal Gains (Losses)
-368
-1,005
-791
-669
Acquired In-Process R&D
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
Abnormal Derivatives
0
0
0
0
Disposal of Assets
0
0
0
0
Early extinguishment of Debt
0
0
0
0
Asset Write-Down
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
Sale of Business
0
0
0
0
Legal Settlement
0
0
0
0
Restructuring Charges
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
Insurance Settlement
0
0
0
0
Other Abnormal Items
0
0
0
0
Pretax Income (Loss)
4,251
3,705
3,486
4,336
Income Tax (Expense) Benefit, net
-784
-640
-811
-798
Current Income Tax
0
0
0
0
Deferred Income Tax
0
0
0
0
Tax Allowance/Credit
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
Income (Loss) from Continuing Operations
3,467
3,065
2,675
3,538
Net Extraordinary Gains (Losses)
0
0
0
0
Discontinued Operations
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
Income (Loss) Including Minority Interest
3,467
3,065
2,675
3,538
Minority Interest
0
0
0
0
Net Income
3,467
3,065
2,675
3,538
Preferred Dividends
0
0
0
0
Other Adjustments
0
0
0
0
Net Income Available to Common Shareholders
3,467
3,065
2,675
3,538
Remarks
restated on Jun 23, 2015 n/a
calculated values,
restated on Jun 28, 2016 n/a
calculated values,
restated on Jun 28, 2016 n/a
calculated values,
restated on Jun 28, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
14,241
19,480
12,634
Cash & Cash Equivalents
n/a
1,403
4,843
2,876
Short Term Investments
n/a
12,838
14,637
9,758
Accounts & Notes Receivable
n/a
3,811
5,112
5,562
Accounts Receivable, Net
n/a
3,811
5,112
5,562
Notes Receivable, Net
n/a
0
0
0
Unbilled Revenues
n/a
0
0
0
Inventories
n/a
1,725
3,463
3,473
Raw Materials
n/a
0
0
0
Work In Process
n/a
0
0
0
Finished Goods
n/a
0
0
0
Other Inventory
n/a
0
0
0
Other Short Term Assets
n/a
1,433
2,789
1,931
Prepaid Expenses
n/a
697
1,454
1,931
Derivative & Hedging Assets
n/a
0
0
0
Assets Held-for-Sale
n/a
0
0
0
Deferred Tax Assets
n/a
736
1,335
0
Income Taxes Receivable
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
Total Current Assets
n/a
21,210
30,844
23,600
Property, Plant & Equipment, Net
n/a
2,392
4,699
4,841
Property, Plant & Equipment
n/a
0
0
9,714
Accumulated Depreciation
n/a
0
0
-4,873
Long Term Investments & Receivables
n/a
0
0
0
Long Term Investments
n/a
0
0
0
Long Term Marketable Securities
n/a
0
0
0
Long Term Receivables
n/a
0
0
0
Other Long Term Assets
n/a
14,341
71,142
71,203
Intangible Assets
n/a
0
0
0
Goodwill
n/a
10,593
40,530
41,500
Other Intangible Assets
n/a
2,286
28,101
26,899
Prepaid Expense
n/a
0
0
0
Deferred Tax Assets
n/a
300
774
1,383
Derivative & Hedging Assets
n/a
0
0
0
Prepaid Pension Costs
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Investments in Affiliates
n/a
0
0
0
Miscellaneous Long Term Assets
n/a
1,162
1,737
1,421
Total Noncurrent Assets
n/a
16,733
75,841
76,044
Total Assets
n/a
37,943
106,685
99,644
Liabilities and owners' equity
Payables & Accruals
n/a
1,921 1921000000
4,156 4156000000
3,421 3421000000
Accounts Payable
n/a
742 742000000
1,610 1610000000
1,709 1709000000
Accrued Taxes
n/a
164 164000000
935 935000000
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
Other Payables & Accruals
n/a
1,015 1015000000
1,611 1611000000
1,712 1712000000
Short Term Debt
n/a
1,613 1613000000
2,434 2434000000
993 993000000
Short Term Borrowings
n/a
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
Other Short Term Liabilities
n/a
2,025 2025000000
2,583 2583000000
2,751 2751000000
Deferred Revenue
n/a
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
19 19000000
119 119000000
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
2,006 2006000000
2,464 2464000000
2,751 2751000000
Total Current Liabilities
n/a
5,559 5559000000
9,173 9173000000
7,165 7165000000
Long Term Debt
n/a
10,315 10315000000
33,752 33752000000
30,109 30109000000
Long Term Borrowings
n/a
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
Other Long Term Liabilities
n/a
2,626 2626000000
10,530 10530000000
10,307 10307000000
Accrued Liabilities
n/a
0 0
0 0
0 0
Pension Liabilities
n/a
662 662000000
1,535 1535000000
1,759 1759000000
Pensions
n/a
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
386 386000000
4,700 4700000000
3,729 3729000000
Derivatives & Hedging
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
1,578 1578000000
4,295 4295000000
4,819 4819000000
Total Noncurrent Liabilities
n/a
12,941 12941000000
44,282 44282000000
40,416 40416000000
Total Liabilities
n/a
18,500 18500000000
53,455 53455000000
47,581 47581000000
Preferred Equity
n/a
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
100 100000000
0 0
0 0
Common Stock
n/a
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
Retained Earnings
n/a
19,940 19940000000
54,414 54414000000
53,931 53931000000
Other Equity
n/a
-597 -597000000
-1,184 -1184000000
-1,868 -1868000000
Equity Before Minority Interest
n/a
19,443 19443000000
53,230 53230000000
52,063 52063000000
Minority Interest
n/a
0 0
0 0
0 0
Total Equity
n/a
19,443 19443000000
53,230 53230000000
52,063 52063000000
Total Liabilities & Equity
n/a
37,943 37943000000
106,685 106685000000
99,644 99644000000
Remarks restated on n/a restated on Jun 23, 2015 n/a restated on Jun 28, 2016 n/a restated on Sep 7, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15FY '16
Net Income/Starting Line
3,467
3,065
2,675
3,538
Net Income
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
Other Adjustments
0
0
0
0
Depreciation & Amortization
819
850
1,306
2,820
Non-Cash Items
296
826
-643
-51
Stock-Based Compensation
0
0
0
0
Deferred Income Taxes
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
Change in Working Capital
360
218
1,564
-1,089
(Increase) Decrease in Accounts Receivable
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
Cash from Operating Activities
4,942
4,959
4,902
5,218
Change in Fixed Assets & Intangibles
-457
-396
-571
-1,046
Disposition of Fixed Assets & Intangibles
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
Net Change in Long Term Investment
-1,810
-2,784
-1,692
4,518
Decrease in Long Term Investment
0
0
0
0
Increase in Long Term Investment
0
0
0
0
Net Cash From Acquisitions & Divestitures
-820
-385
-14,884
-1,213
Net Cash from Divestitures
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
Cash for Joint Ventures
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
Other Investing Activities
-14
-29
89
-14
Net Cash From Discontinued Operations (investing)
0
0
0
0
Cash from Investing Activities
-3,101
-3,594
-17,058
2,245
Dividends Paid
-1,055
-1,116
-1,337
-2,139
Cash From (Repayment of) Debt
-26
1,431
18,673
-5,125
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
Cash From Long Term Debt
0
0
0
0
Cash From (Repurchase of) Equity
-980
-1,246
-1,271
-2,339
Increase in Capital Stock
267
1,307
649
491
Decrease in Capital Stock
-1,247
-2,553
-1,920
-2,830
Other Financing Activities
-40
13
-116
60
Net Cash From Discontinued Operations (financing)
0
0
0
0
Cash from Financing Activities
-2,101
-918
15,949
-9,543
Net Cash Before Disc. Operations and FX
-260
447
3,793
-2,080
Change in Cash from Disc. Operations and Other
0
0
0
0
Net Cash Before FX
-260
447
3,793
-2,080
Effect of Foreign Exchange Rates
7
37
-353
113
Net Changes in Cash
-253
484
3,440
-1,967
Remarks
restated on Jun 23, 2015 n/a
calculated values,
restated on Jun 28, 2016 n/a
calculated values,
restated on Jun 28, 2016 n/a
calculated values,
restated on Jun 28, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo